Welcome to LookChem.com Sign In|Join Free

CAS

  • or

1520010-86-9

Post Buying Request

1520010-86-9 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1520010-86-9 Usage

Description

Sofosbuvir Impurity is a chemical compound that is considered an impurity in the pharmaceutical product sofosbuvir, which is used to treat chronic hepatitis C. It is a potential metabolite of sofosbuvir and possesses significant importance in the pharmaceutical industry for testing and quality control purposes.

Uses

Used in Pharmaceutical Industry:
Sofosbuvir Impurity is used as a reference standard for testing and quality control purposes in the pharmaceutical industry. It is utilized to check the purity of sofosbuvir and ensure that no harmful or undesired substances are present in the pharmaceutical product. This helps maintain the safety and efficacy of the drug for patient use.
Sofosbuvir Impurity is also used for assessing the stability and degradation products of sofosbuvir. By analyzing the presence and quantity of this impurity, pharmaceutical companies can guarantee the stability and quality of the drug, ensuring its safety and efficacy for patient use. This is crucial in maintaining the overall quality and reliability of the pharmaceutical product in the market.

Check Digit Verification of cas no

The CAS Registry Mumber 1520010-86-9 includes 10 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 7 digits, 1,5,2,0,0,1 and 0 respectively; the second part has 2 digits, 8 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 1520010-86:
(9*1)+(8*5)+(7*2)+(6*0)+(5*0)+(4*1)+(3*0)+(2*8)+(1*6)=89
89 % 10 = 9
So 1520010-86-9 is a valid CAS Registry Number.

1520010-86-9Relevant articles and documents

Preparation method and application of thyroid hormone receptor beta subtype agonist derivative

-

Paragraph 0069; 0079-0083, (2020/04/17)

The invention relates to a thyroid hormone receptor beta subtype agonist derivative as shown in a general formula (I) which is described in the specification and a preparation method thereof. The invention also discloses application of the derivative in preparation of medicines for treating related diseases (related illnesses and diseases such as obesity, hyperlipidemia, hypercholesterolemia and diabetes and related illnesses and diseases such as alcoholic steatohepatitis, atherosclerosis, cardiovascular diseases and hypothyroidism).

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1520010-86-9